Kaumudi Bhawe earned her PhD from the Robert Stempel College of Public Health & Social Work at Florida International University, where she was a recipient of the Dean’s Award of Excellence for her doctoral dissertation research, in which she discovered and characterized NRF1 transcription factor activity associated with advanced brain cancer.
Dr. Bhawe has presented at national conferences, and some of her most recent work has been published in the journal Molecular Neurobiology. She has more than 15 years of drug development experience in the biotechnology industry, following her initial graduate training at Rensselaer Polytechnic Institute as a Biomedical Engineer. She has led cross-functional research projects in multiple biotech companies in the San Francisco Bay Area, including Genentech.
Dr. Bhawe has a deep understanding of oncology signal transduction and expertise in numerous modern biological techniques, and she has successfully contributed to cancer drug discovery, target validation, assay development, companion diagnostics, and clinical development of novel cancer therapies. Dr. Bhawe has devoted her career to improving the treatment of cancer patients, from bench to bedside.